Space pharmacology

Last updated
Scientists and astronauts Kathryn D. Sullivan and Bruce McCandless I are performing medical studies on Central Venous Pressure and associated drug-related studies. STS-31 MS Sullivan, MS McCandless, DSO 462 medical device on OV-103 middeck.jpg
Scientists and astronauts Kathryn D. Sullivan and Bruce McCandless I are performing medical studies on Central Venous Pressure and associated drug-related studies.

Space pharmacology is the application of biomedical engineering that studies the use and dynamics of drugs or pharmaceuticals in space environments. Falling in the realm of space medicine, outer space drug delivery is the practical application of using drugs to treat disorders that may arise due to space’s extreme conditions, such as microgravity, radiation, and other physiological and psychological risks. The physical conditions and hazards posed by outer space conditions can result in space-related disorders to the human body, posing a necessity to manufacture, modify, and test drugs to work in outer space.

Contents

History of space medicine and drug delivery

Concerns about aviation drug delivery started as early as 1924 when orthostatic stress was found to be the reason for a pilot’s inability to digest chocolate during a flight. [2] In addition, studies on the effect of digitalis on altitude were performed on both pigeons and cats in 1924, concluding that increased altitudes significantly increase the effects of digitalis on their systems, leading to a recommendation to decrease the dosage of digitalis in high altitudes to be two-fifths of the current dose. [2]

As outer space expeditions grew in the mid-twentieth century, missions established medical practices to deliver medicines for astronauts in missions. Project Apollo in the late 1960s to early 1970s began the use of using medicine bags, which came with commonly-used drugs for motion sickness and pain relief in oral form (tablets and capsules) as well as a nasal spray. [3] The Mercury Project was one of the first space expeditions to take medicine delivery to outer space. Injector systems were first developed and used then to deliver and inject drugs directly into an individual’s spacesuit into their thighs. [3] These injection tubes were used to deliver Tigan and Demerol, respectively, motion sickness and pain relief drugs. [3] Studies in the 1980s examined common orally-delivered drug functionalities in altered space environments, beginning with acetaminophen, concluding that they were less effective in outer space.

Environmental conditions that impact pharmacological dynamics of drugs

Several conditions of cells can change due to the effects of short-term and long-term spaceflight. Cells in Space.jpg
Several conditions of cells can change due to the effects of short-term and long-term spaceflight.

Several studies in the past have relied on the assumption that a drug’s action would not be compromised when a subject and/or drug are placed in altered environments. However, the effect of outer space on the subject has been a recent concern on drug delivery and mechanism. There is a need to modify drug doses and release profiles to achieve maximum drug efficacy in outer space due to environmental implications on the human body. There are several conditions that NASA has identified that impact human physiology, affecting the pharmacological capabilities of drugs: Space Radiation, Isolation and Confinement, Distance from Earth, Gravity fields, and Hostile/Closed Environments (RIDGE), affecting drug absorption, distribution, metabolism, and excretion. [5]

Radiation

Radiation exposure is increased in astronauts primarily due to low dose-rate galactic cosmic rays and intermittent solar particle events. [5] This increased radiation exposure can cause epigenetic changes, including DNA double-stranded breaks, altered methylation patterns, and telomere lengths, increasing the risk of developing carcinogenesis, degenerative diseases, and central nervous system effects. [5] In addition, radiation can impact drug synthesis, such as the development of toxic by-products, drug stability … etc. The most common type of radiation found in outer space is called direct ionization, which can strike target molecules and can cause the rupture of chemical bonds and destroy polymer structures, while indirect ionization is when radiation hits water instead of a target, generating radiolitic products. that can diffuse and damage a target molecule within range. [5] Because of this, liquid drug formulations are more unstable than solid drugs due to oxygen radical species forming in liquid conditions. Current solutions investigate using adequate packaging, storing excipients and drugs separately and in their solid or powdered form, or storing them at cryogenic temperatures. [5]

Microgravity

The effects of microgravity can be seen in the human body, beginning with a shift upwards in fluid, called the cephalad fluid shift. This can also cause other muscle and bodily disorientation as well. Microgravity.png
The effects of microgravity can be seen in the human body, beginning with a shift upwards in fluid, called the cephalad fluid shift. This can also cause other muscle and bodily disorientation as well.

Microgravity is the condition of low gravity found in outer space. Some of the major physiological implications that are associated with microgravity are bone loss, immunosuppression, enlargement of bones, muscle loss and movement of body fluids towards the head, spaceflight osteopenia, decrease in the function of cardiovascular system functions, decreased production of red blood cells, balance disorders, and also weaken the human immune system. [3] In addition to this, fluid distribution is increased in the upper body due to the body’s ability to pump blood faster to the upper body in microgravity conditions, known as the cephalad fluid shift. [3] [5] In addition, muscle regeneration protein levels have been estimated to vary due to microgravity conditions, including myostatin, activin A, and certain cytokines (e.g. IL-6, IL-10, IL-1ra), which are currently used as targets for drug delivery applications. [3] The effects of microgravity has also investigated in wound healing processes, especially with the behavior of cell populations, such as fibroblasts. [7] For cell studies, a Rotary Cell Culture System was used to mimic cell conditions in microgravity, where the bioreactor rotates horizontally, causing cell sedimentation in the vessel to be offset by the rotating fluid. [7] This results in this light falling of cells, simulated in a microgravity environment. Studies showed a rearrangement of microtubules in cells due to microgravity, forming a dense, puzzled, network, unlike fibroblasts in a normal environment, which exhibit radial parallel formations. [7] Several proteins in the wound repair process that are expressed by fibroblast activation, such as SMA, VEGF, and E-CAD proteins, were repressed or significantly decreased. [7] However, pro-inflammatory signals, such as COX-2, were shown to increase by 87%. [7] Another physiological factor affected by microgravity are membrane pores in cells. It was studied that under hypergravity, porins are increased while they are decreased in microgravity environments, which can impact drug metabolism and intake. [8] Drug studies have shown potential advantages with microgravity conditions, such as less particle sedimentation or coalescence, however, microgravity conditions prevent the removal of air bubbles in injectable drug formulations, posing challenges for liquid drug infusions. [5] In addition, best-rest models are used on Earth to study the pharmacodynamics of drugs in microgravity conditions. [5]

Other conditions

A list of possible physiological changes that can occur due to spaceflight. This can also affect how drugs react to the body. Physiological Response to Spaceflight.jpg
A list of possible physiological changes that can occur due to spaceflight. This can also affect how drugs react to the body.

One condition that can affect the pharmacological properties of drugs is protein degradation caused by spaceflight, predicted to be associated with adaptive downsizing of the antigravity muscles and the energy deficit. [10] This is seen in other responses, such as fight-or-flight, the presence of a new pathogen or virus, or some sort of injury to the body. [10] Other conditions that affect the pharmacological capabilities of drugs are hypoxia, where drug antagonism is almost negligible in lower blood oxygen levels and physiologic enzyme conditions are limited in high oxygen tension conditions. [2] In addition, diuretics cans shift the oxygen-hemoglobin curve, affecting drug performance. 

Drug testing, manufacturing, and drug delivery technologies for outer space

Drug testing

Several pharmacokinetic studies have been performed on stimulated weightlessness and increased radiation conditions on common drugs to analyze their effects on physiology.

Acetaminophen

One of the main types of drug studies conducted is using astronauts as test subjects and measuring drug dynamics before and after spacecraft flight. A study on acetaminophen pharmacokinetics was performed on ten astronauts, studying its concentration dynamics in saliva two months before spaceflight and during long-term spaceflight. [11] Saliva samples were analyzed at intervals of 0.017, 0.33, 0.5, 0.75, 1, 2, 4, and 6 hours after acetaminophen intake by HPLC with UV spectrophotometric detection at 254 nm. [11] Some of the key factors identified post-spaceflight was that the absorption of acetaminophen was delayed after tablet administration during spaceflight and the bioavailability of the encapsulated drug was found to moderately decrease during spaceflight. [11]  

Promethazine

Promethazine is one of the recommended drugs by NASA to treat space motion sickness and studies have been conducted to analyze their pharmacological responses in outer space. Studies on promethazine were performed exclusively on Earth, called earthbound models, stimulating microgravity and weightlessness through forty-eight hours of bed rest. [12] The −6° head-down best rest model, where individuals are placed lying 6 degrees down to study weightlessness. [12] This type of model simulates the shift in fluid from the bottom to the top of the body, as well as bone loss, found in astronauts in weightless environments. [12] Using twelve volunteers, 50 mg of promethazine was delivered orally or intramuscularly to the deltoid muscle before and after forty-eight hours of bedrest. [12] Blood was examined at intervals of 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 16, 24, 36, and 48 hours post-drug deliverance and promethazine levels were detected using plasma promethazine assays, which uses liquid chromatography to quantify promethazine kinetics. [12] The study determined that higher concentrations of promethazine were found in the blood through oral delivery and bioavailability factors was impacted through weightlessness. [12]

Ciprofloxacin

Due to the constraints and confined environments that astronauts are exposed to for long durations of time, they are at risk for higher rates of infection. Ciprofloxacin is a common drug used to treat infections, especially bacterial of nature, and is used to study antibiotics delivery in outer space due to its good bioavailability, infrequent dose intake, multiple-dose intake abilities (oral or intravenous), and stability. [13] This study also employs a bed-rest model called the antiorthostatis bed rest (ABR) model, where subjects lie at a 12° angle downwards to simulate space flight weightlessness. [13] Six individuals were employed to take one dose of 250 mg ciprofloxacin, once at weightlessness and once at normal conditions, separated between fifteen days. [13] Blood was examined at intervals of 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 8, and 12 hours and urine samples were also collected at 0, 3, 6, 8, and 12 hours after each dose. [13] It was found that ciprofloxacin’s penetration in the tissue was lower in microgravity conditions than normal, indicating tissue penetration to be an issue in outer space for ciprofloxacin. [13] In addition, compared to doses stored at ground versus in space, there was visible discoloration in samples stored in outer space and the expiration period in outer space was much shorter than on the ground. [14]

Drug manufacturing

Due to the environmental factors present in outer space, alternative manufacturing methods are explored to produce medicines for astronaut use. For example, measuring the weight and volume of medicine ingredients in microgravity conditions is difficult and requires zero-gravity mass measurement devices. [3] Current manufacturing methods also rely heavily on large and heavy machining, which cannot fit on spacecraft due to constrained spaces. [3] New manufacturing methods for medicines have been developed that can adapt to outer space’s environmental constraints. Chemputing is a chemical-robot system that uses limited technology to synthesize raw materials for pharmaceuticals. [5] This apparatus includes a reaction flask, a jacketed filtration setup, an automated liquid-liquid separation module, and a solvent evaporation module, allowing astronauts to develop compounds on demand, not requiring a large space and taking into account the constraints of spaceflight. [5] Additive manufacturing has already been used on Earth in the personalized medicine field and there are methods sent to outer space for drug manufacturing and fabrication. Some forms of fabrication tested in outer space are fused deposition printing, which employs 3D printing methods to print using layer-by-layer filament extrusions, semi-solid and direct powder extrusion, effective for bioprinting applications and can be leveraged to process materials found in outer space (silica, magnesium silicate, and calcium phosphate), and photopolymerization, which uses light to print a resin in a layer-by-layer mechanism. [5] These methods are not only used for drug manufacturing but also for biomaterials or medical devices that can load drugs. Finally, methods are used to conduct quality assurance, such as gas chromatography, mass spectrometry, infrared spectroscopy, nuclear magnetic resonance spectroscopy, and other such techniques to identify potential toxins in drug formulations. [5]   Advances in handheld, portable, and component miniaturization have developed spectroscopy methods to be more accessible for outer space applications. [5] For example, Raman spectroscopy is a handheld device that can measure drug degradation and drug parameters and efficacy. [5]

Medicine storage and usage by astronauts

Medication storage and on-site production have become crucial areas of research due to extensive periods away from Earth. Factors, such as shelf life and drug stability, on drug storage, are impacted due to the effects of radiation, long space flight durations, and microgravity. Current solutions aim at frequent missions to resupply and restock medicines and commonly used drugs, however, this is not possible for long-term spaceflight to Mars or other distant missions. [5] In addition, due to the toll that spaceflight takes on the human body, medicine use by astronauts have been extensively studied. High rates of sleep medication are taken by astronauts to combat sleep deprivation, disturbances, and other sleep-related disorders caused by an increased presence of CO2 in the International Space Station. [15] Medications for congestion and allergies, combined with headache-related medications, are also significantly used, primarily because of the cephalad fluid shifts caused by a transition to weightless environment. [15]

Drug delivery technologies for outer space

The need for developing drug delivery mechanisms that can accurately control dose frequency, concentration, and amount, for extreme conditions has grown as astronauts take on more extreme space exploration missions. Regenerative therapies have also gained prominence in space medicine. Microgravity conditions lead to bone loss due to repressing osteoblast growth, contributing to traumatic fractures, injuries, and extensive wound generation, requiring surgical intervention. [16] Using a concept called facilitated endogenous repair, scientists are developing scaffolds to deliver drugs or other agents to promote normal physiology at an injury site. [16] In addition, tunable nanoparticles are also being investigated to maintain mechanical integrity when distribbuted to bone injuries for repair. [16]

Related Research Articles

<span class="mw-page-title-main">Astronaut</span> Commander, pilot, or crew member of a spacecraft

An astronaut is a person trained, equipped, and deployed by a human spaceflight program to serve as a commander or crew member aboard a spacecraft. Although generally reserved for professional space travelers, the term is sometimes applied to anyone who travels into space, including scientists, politicians, journalists, and tourists.

<span class="mw-page-title-main">STS-41</span> 1990 American crewed spaceflight to deploy Ulysses

STS-41 was the 36th Space Shuttle mission and the eleventh mission of the Space Shuttle Discovery. The four-day mission had a primary objective of launching the Ulysses probe as part of the "International Solar Polar Mission" (ISPM).

<span class="mw-page-title-main">Space adaptation syndrome</span> Condition caused by weightlessness

Space adaptation syndrome (SAS) or space sickness is a condition experienced by as many as half of all space travelers during their adaptation to weightlessness once in orbit. It is the opposite of terrestrial motion sickness since it occurs when the environment and the person appear visually to be in motion relative to one another even though there is no corresponding sensation of bodily movement originating from the vestibular system.

<span class="mw-page-title-main">Effect of spaceflight on the human body</span> Medical issues associated with spaceflight

The effects of spaceflight on the human body are complex and largely harmful over both short and long term. Significant adverse effects of long-term weightlessness include muscle atrophy and deterioration of the skeleton. Other significant effects include a slowing of cardiovascular system functions, decreased production of red blood cells, balance disorders, eyesight disorders and changes in the immune system. Additional symptoms include fluid redistribution, loss of body mass, nasal congestion, sleep disturbance, and excess flatulence. Overall, NASA refers to the various deleterious effects of spaceflight on the human body by the acronym RIDGE.

<span class="mw-page-title-main">Space medicine</span> For health conditions encountered during spaceflight

Space medicine is an area in aerospace medicine that focuses on the medical care of astronauts and spaceflight participants. The spaceflight environment poses many unique stressors to the human body, including G forces, microgravity, unusual atmospheres such as low pressure or high carbon dioxide, and space radiation. Space medicine applies space physiology, preventive medicine, primary care, emergency medicine, acute care medicine, austere medicine, public health, and toxicology to prevent and treat medical problems in space. This expertise is additionally used to inform vehicle systems design to minimize the risk to human health and performance while meeting mission objectives.

<span class="mw-page-title-main">Neutral Buoyancy Laboratory</span> NASA astronaut training facility in Houston, Texas

The Neutral Buoyancy Laboratory (NBL) is an astronaut training facility and neutral buoyancy pool operated by NASA and located at the Sonny Carter Training Facility, near the Johnson Space Center in Houston, Texas. The NBL's main feature is a large indoor pool of water, in which astronauts may perform simulated EVA tasks in preparation for upcoming missions. Trainees wear suits designed to provide neutral buoyancy to simulate the microgravity that astronauts experience during spaceflight.

The conditions governing sex in space have become a necessary study due to plans for long-duration space missions, as well as the future potential accommodation of sexual partners aboard the International Space Station (ISS). Issues explored include disrupted circadian rhythms, radiation, isolation, stress, and the physical acts of intercourse in zero or minimal gravity.

<span class="mw-page-title-main">Bioastronautics</span> Academic discipline

Bioastronautics is a specialty area of biological and astronautical research which encompasses numerous aspects of biological, behavioral, and medical concern governing humans and other living organisms in a space flight environment; and includes design of payloads, space habitats, and life-support systems. In short, it spans the study and support of life in space.

Astronautical hygiene evaluates, and mitigates, hazards and health risks to those working in low-gravity environments. The discipline of astronautical hygiene includes such topics as the use and maintenance of life support systems, the risks of the extravehicular activity, the risks of exposure to chemicals or radiation, the characterization of hazards, human factor issues, and the development of risk management strategies. Astronautical hygiene works side by side with space medicine to ensure that astronauts are healthy and safe when working in space.

Health threats from cosmic rays are the dangers posed by cosmic rays to astronauts on interplanetary missions or any missions that venture through the Van-Allen Belts or outside the Earth's magnetosphere. They are one of the greatest barriers standing in the way of plans for interplanetary travel by crewed spacecraft, but space radiation health risks also occur for missions in low Earth orbit such as the International Space Station (ISS).

<span class="mw-page-title-main">Weightlessness</span> Zero apparent weight, microgravity

Weightlessness is the complete or near-complete absence of the sensation of weight, i.e., zero apparent weight. It is also termed zero g-force, or zero-g or, incorrectly, zero gravity.

ELIPS - European Programme for Life and Physical Sciences in Space and applications utilising the International Space Station started in 2001 and was intended to cover the activities for the following 5 years. This Microgravity Programme at the European Space Agency (ESA) is an optional programme, with currently 17 ESA member states participating. The ELIPS programme prepares and performs research on the International Space Station, and other uncrewed mission platforms like Sounding Rockets, in fundamental and applied life and physical sciences. ELIPS is the continuation of the earlier European microgravity programmes EMIR 1&2, and the Microgravity Facilities for Columbus, MFC.

Space neuroscience or astroneuroscience is the scientific study of the central nervous system (CNS) functions during spaceflight. Living systems can integrate the inputs from the senses to navigate in their environment and to coordinate posture, locomotion, and eye movements. Gravity has a fundamental role in controlling these functions. In weightlessness during spaceflight, integrating the sensory inputs and coordinating motor responses is harder to do because gravity is no longer sensed during free-fall. For example, the otolith organs of the vestibular system no longer signal head tilt relative to gravity when standing. However, they can still sense head translation during body motion. Ambiguities and changes in how the gravitational input is processed can lead to potential errors in perception, which affects spatial orientation and mental representation. Dysfunctions of the vestibular system are common during and immediately after spaceflight, such as space motion sickness in orbit and balance disorders after return to Earth.

<span class="mw-page-title-main">Astronaut training</span> Preparing astronauts for space missions

Astronaut training describes the complex process of preparing astronauts in regions around the world for their space missions before, during and after the flight, which includes medical tests, physical training, extra-vehicular activity (EVA) training, procedure training, rehabilitation process, as well as training on experiments they will accomplish during their stay in space.

It is inevitable that medical conditions of varying complexity, severity and emergency will occur during spaceflight missions with human participants. Different levels of care are required depending on the problem, available resources and time required to return to Earth.

Even before the very beginning of human space exploration, serious and reasonable concerns were expressed about exposure of humans to the microgravity of space due to the potential systemic effects on terrestrially-evolved life forms adapted to Earth gravity. Unloading of skeletal muscle, both on Earth via bed-rest experiments and during spaceflight, result in remodeling of muscle. As a result, decrements occur in skeletal muscle strength, fatigue resistance, motor performance, and connective tissue integrity. In addition, there are cardiopulmonary and vascular changes, including a significant decrease in red blood cell mass, that affect skeletal muscle function. This normal adaptive response to the microgravity environment may become a liability resulting in increased risk of an inability or decreased efficiency in crewmember performance of physically demanding tasks during extravehicular activity (EVA) or upon return to Earth.

Heart rhythm disturbances have been seen among astronauts. Most of these have been related to cardiovascular disease, but it is not clear whether this was due to pre-existing conditions or effects of space flight. It is hoped that advanced screening for coronary disease has greatly mitigated this risk. Other heart rhythm problems, such as atrial fibrillation, can develop over time, necessitating periodic screening of crewmembers’ heart rhythms. Beyond these terrestrial heart risks, some concern exists that prolonged exposure to microgravity may lead to heart rhythm disturbances. Although this has not been observed to date, further surveillance is warranted.

The following page is a list of scientific research that is currently underway or has been previously studied on the International Space Station by the European Space Agency.

<span class="mw-page-title-main">Locomotion in space</span> Movement of astronauts bodies in outer space

Locomotion in space includes all actions or methods used to move one's body in microgravity conditions through the outer space environment. Locomotion in these conditions is different from locomotion in a gravitational field. There are many factors that contribute to these differences, and they are crucial when researching long-term survival of humans in space.

The ISS U.S. National Lab, commonly known as the ISS National Lab, is a U.S. government-funded national laboratory established on 30 December 2005 by the 2005 NASA Authorization Act. With principal research facilities located in the United States Orbital Segment (USOS) of the International Space Station (ISS), the Laboratory conducts research in life sciences, physical sciences, technology development and remote sensing for a broad range of academic, government and commercial users. Of the 270 payloads that the Center for the Advancement of Science in Space (CASIS) has sent to the ISS, 176 have been for commercial companies including Merck & Co., Novartis, Eli Lilly and Company, Hewlett Packard Enterprise, Honeywell, and Procter & Gamble.

References

  1. ↑ "NASA Image and Video Library". NASA Image and Video Library. Retrieved 2023-04-20.
  2. 1 2 3 Perry, Carlos J. G. (November 1965). "Drugs in aerospace medicine". Clinical Pharmacology & Therapeutics. 6 (6): 771–787. doi:10.1002/cpt196566771. PMID   5321223. S2CID   42967308.
  3. 1 2 3 4 5 6 7 8 Santhosh Kumar, Venugopalan; Kumar, Abhijeet; Kumari, Neelam; Sri, Sundar; T, Shanmugarajan; P, Shanmugasundaram (November 2, 2015). "Space Pharmacology: An Overview". International Journal of Frontiers in Science and Technology Research. 3 (3): 228–238.
  4. ↑ Johnson, NASA (2015-01-14), Cells in Space , retrieved 2023-04-20
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Seoane-Viaño, Iria; Ong, Jun Jie; Basit, Abdul W.; Goyanes, Alvaro (December 2022). "To infinity and beyond: Strategies for fabricating medicines in outer space". International Journal of Pharmaceutics: X. 4: 100121. doi:10.1016/j.ijpx.2022.100121. ISSN   2590-1567. PMC   9240807 . PMID   35782363.
  6. ↑ "NASA", Wikipedia, 2023-04-19, retrieved 2023-04-20
  7. 1 2 3 4 5 Cialdai, Francesca; Vignali, Leonardo; Morbidelli, Lucia; Colciago, Alessandra; Celotti, Fabio; Santi, Alice; Caselli, Anna; Cirri, Paolo; Monici, Monica (2017-01-18). "Modeled Microgravity Affects Fibroblast Functions Related to Wound Healing". Microgravity Science and Technology. 29 (1–2): 121–132. Bibcode:2017MicST..29..121C. doi:10.1007/s12217-016-9532-7. hdl: 2158/1160113 . ISSN   0938-0108. S2CID   255562256.
  8. ↑ Goldermann, Markus; Hanke, Wolfgang (March 2001). "Ion channel are sensitive to gravity changes". Microgravity Science and Technology. 13 (1): 35–38. Bibcode:2001MicST..13...35G. doi:10.1007/bf02873330. ISSN   0938-0108. PMID   12043748. S2CID   37919538.
  9. ↑ Johnson, NASA (2015-01-14), Physiological Response to Spaceflight , retrieved 2023-04-20
  10. 1 2 Stein, T. P.; Leskiw, M. J.; Schluter, M. D.; Donaldson, M. R.; Larina, I. (1999-06-01). "Protein kinetics during and after long-duration spaceflight on MIR". American Journal of Physiology. Endocrinology and Metabolism. 276 (6): E1014–E1021. doi:10.1152/ajpendo.1999.276.6.E1014. ISSN   0193-1849. PMID   10362613.
  11. 1 2 3 Kovachevich, I. V.; Kondratenko, S. N.; Starodubtsev, A. K.; Repenkova, L. G. (March 2009). "Pharmacokinetics of acetaminophen administered in tablets and capsules under long-term space flight conditions". Pharmaceutical Chemistry Journal. 43 (3): 130–133. doi:10.1007/s11094-009-0255-6. ISSN   0091-150X. S2CID   29934457.
  12. 1 2 3 4 5 6 Gandia, Peggy; Saivin, Sylvie; Le-Traon, Anne Pavy; Guell, Antonio; Houin, Georges (September 2006). "Influence of Simulated Weightlessness on the Intramuscular and Oral Pharmacokinetics of Promethazine in 12 Human Volunteers". The Journal of Clinical Pharmacology. 46 (9): 1008–1016. doi:10.1177/0091270006291032. ISSN   0091-2700. PMID   16920895. S2CID   23928118.
  13. 1 2 3 4 5 Schuck, Edgar L.; Grant, Maria; Derendorf, Hartmut (July 2005). "Effect of Simulated Microgravity on the Disposition and Tissue Penetration of Ciprofloxacin in Healthy Volunteers". The Journal of Clinical Pharmacology. 45 (7): 822–831. doi:10.1177/0091270005276620. PMID   15951472. S2CID   29616990.
  14. ↑ Du, Brian; Daniels, Vernie R.; Vaksman, Zalman; Boyd, Jason L.; Crady, Camille; Putcha, Lakshmi (2011-06-01). "Evaluation of Physical and Chemical Changes in Pharmaceuticals Flown on Space Missions". The AAPS Journal. 13 (2): 299–308. doi:10.1208/s12248-011-9270-0. ISSN   1550-7416. PMC   3085701 . PMID   21479701.
  15. 1 2 Wotring, Virginia E. (July 17, 2015). "Medication use by U.S. crewmembers on the International Space Station". The FASEB Journal. 29 (11): 4417–4423. doi: 10.1096/fj.14-264838 . hdl: 2060/20140017010 . PMID   26187345. S2CID   205373370.
  16. 1 2 3 Grattoni, Alessandro; Tasciotti, Ennio; Fine, Daniel; Fernandez-Moure, Joseph S.; Sakamoto, Jason; Hu, Ye; Weiner, Bradley; Ferrari, Mauro; Parazynski, Scott (2012-11-01). "Nanotechnologies and Regenerative Medical Approaches for Space and Terrestrial Medicine". Aviation, Space, and Environmental Medicine. 83 (11): 1025–1036. doi:10.3357/ASEM.3307.2012. PMID   23156089.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.